Functional, morphological and electrocardiographical abnormalities in patients with apical hypertrophic

Kenichiro Suwa1, Hiroshi Satoh2, Makoto Sano1

  • 1The Investigator Group , Hamamatsu Circulation Forum ; (Hamamatsu Circulation Forum consists of Enshu Hospital, Hamamatsu University Hospital, Hamamatsu Red Cross Hospital, Kosai General Hospital and Seirei Mikatahara Hospital.).

Open Heart
|October 22, 2014
PubMed

Insights

Cardiac MRI (CMR) is superior to echocardiography for assessing apical abnormalities in hypertrophic cardiomyopathy. Fragmented QRS (fQRS) may indicate early apical myocardial injury.

Area of Science:

  • Cardiology
  • Medical Imaging
  • Electrophysiology

Background:

  • Apical hypertrophic cardiomyopathy (APH) typically has a benign prognosis.
  • However, apical myocardial injury can significantly impact patient outcomes.
  • Identifying markers of apical injury is crucial for risk stratification.

Purpose of the Study:

  • To evaluate functional, morphological, and electrocardiographical abnormalities in patients with APH and apical aneurysm.
  • To identify parameters associated with apical myocardial injury in these patients.

Main Methods:

  • A multicentre, cross-sectional study involving 45 patients with APH and 5 with apical aneurysm.
  • Cardiac MRI (CMR) assessed apical contraction and myocardial fibrotic scar (late gadolinium enhancement - LGE).
  • Electrocardiography (ECG) identified QRS fragmentation (fQRS).

Main Results:

  • CMR revealed abnormalities in apical contraction missed by TTE in 48% of patients.
  • Apical LGE was significantly more prevalent in patients with hypokinetic or dyskinetic apical contraction compared to normal contraction (p<0.01).
  • fQRS was strongly associated with impaired apical contraction and apical LGE (OR=8.32 and 8.61, p<0.05).

Conclusions:

  • CMR is superior to TTE for analyzing apical abnormalities in APH and apical aneurysm.
  • Fragmented QRS (fQRS) shows promise as an early indicator of apical myocardial injury.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
789
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
1.1K
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
806
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
540
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
578
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
766